30 Day Trial

About ORTHOWORLD

Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.

ORTHOFLASH Subscribe

01/19/2018
  • 9:15 a.m. Smith & Nephew observed a 97.3% decrease in hospital readmissions following total joint arthroplasties conducted under its eCAP/Episode of Care Assurance Program
 
01/18/2018
  • 10:00 a.m. The WHITE Four randomized control trial, comparing the X-Bolt expanding bolt device to a sliding hip screw, has surpassed enrollment of 1,000 patients.
  • Episurf Medical received approval to market Episealer® knee products in Israel, to be distributed by AMI Technologies.
Read More

Articles of Interest All Articles

Survey: In 2018 and Beyond, Where do Opportunities Lie for You and Your Company?

ORTHOWORLD is conducting an Orthopaedic Industry Survey, an 8-question survey that we estimate takes just 3 minutes to complete.